BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
DRD2
,
Fatty acid metabolic process
,
Ischemia
,
Liver
,
Trichostatin A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
XIAP protein
Summary
General Info
Curated Studies
Most Correlated Studies
XIAP knockdown in HCT116 colon cancer cells
Acute myeloid leukemia resistance to inhibitor of apoptosis protein antagonist BV6
Pancreatic cancer in KPC mouse model after CTGF inhibition and gemcitabine treatment
Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Chronic lymphocytic leukemia cells treated with CDKI-73 and fludarabine
Explore Curated Studies Results
Literature
Most Relevant Literature
N-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and…
Overexpression of XIAP inhibits cisplatin-induced hair cell loss.
Interplay of p53 and XIAP protein dynamics orchestrates cell fate in response to chemotherapy.
Maternal Gonosomal Mosaicism Causes XIAP Deficiency.
SP1-stimulated miR-208a-5p aggravates sepsis-induced myocardial injury via targeting XIAP.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carci…
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ